Почетна › Немалоклетни карцином плућа › Јужна Каролина › Charleston
Kliničke studije za Немалоклетни карцином плућа u gradu Charleston, SC
16 studija za Немалоклетни карцином плућа traži učesnike na lokacijama u gradu Charleston i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Тражи се учесникФаза 3
- Bon Secours Saint Francis Hospital, Charleston
- Medical University of South Carolina, Charleston
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Тражи се учесникФаза 3
- Medical University of South Carolina-Hollings Cancer Center ( Site 0045), Charleston
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Тражи се учесникФаза 3
- Medical University of South Carolina, Charleston
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Тражи се учесникОпсервациона студија
- Medical University of South Carolina, Charleston
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Тражи се учесникФаза 3
- Medical University of South Carolina, Charleston
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
Тражи се учесникФаза 2
- Medical University of South Carolina, Charleston
Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint Inhibitor Therapy
Тражи се учесникФаза 3
- Medical University of South Carolina, Charleston
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
Тражи се учесникФаза 2
- USA03-0, Charleston
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Тражи се учесникФаза 2
- Medical University of South Carolina /ID# 273272, Charleston
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Тражи се учесникФаза 1/2
- Research Site 123, Charleston
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Тражи се учесникФаза 2
- Ralph H Johnson VA Medical Center, Charleston
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Тражи се учесникФаза 2/3
- Medical University of South Carolina, Charleston
Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors
Тражи се учесникФаза 1/2
- MUSC Hollings Cancer Center, Charleston
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Тражи се учесникФаза 2
- Ralph H Johnson VA Medical Center, Charleston
- Medical University of South Carolina, Charleston
Phase 2 Study of Fingolimod in Lung Cancers
Тражи се учесникФаза 2
- Hollings Cancer Center at Medical University of South Carolina, Charleston
GEMINI-NSCLC: NSCLC Biomarker Study
Тражи се учесникОпсервациона студија
- The Medical University of South Carolina, Charleston
Studije za Немалоклетни карцином плућа u drugim gradovima
- Houston, TX143 студија
- New York City, NY123 студија
- Arlington, VA111 студија
- Nashville, TN97 студија
- Los Angeles, CA92 студија
- Boston, MA87 студија
- St. Louis, MO68 студија
- Baltimore, MD60 студија
- San Antonio, TX60 студија
- Chicago, IL59 студија
- Columbus, OH57 студија
- Seattle, WA55 студија
Ostale studije u gradu Charleston
- Шлог19 студија
- Депресија18 студија
- Posttraumatski stresni poremećaj16 студија
- Плоскоклеточни карцином главе и врата16 студија
- Затајење срца16 студија
- Рак простате16 студија
- Кардиоваскуларне болести16 студија
- Рак (све врсте)14 студија
- Паркинсонова болест13 студија
- Рак дојке12 студија
- Рак плућа12 студија
- Интерстицијалне болести плућа11 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.